Chronic Obstructive Respiratory Disease (COPD)
The following areas are of research interest:
- Measures of exercise endurance (e.g. cycle-ergometry, treadmill, walk or step tests) and physical activity and how this may translate to activities of daily living in COPD
- Health care utilization associated with exacerbations and hospitalizations and transition of care for COPD exacerbations
- Community practice interventions and the impact of increased community practice awareness and screening on diagnosis and management of COPD and adherence to COPD therapy
- Impact of other chronic diseases (e.g. cardiovascular, diabetes, anxiety/depression) on the diagnosis, management and outcomes of COPD and vice versa
- Novel clinical endpoints, biomarkers/inflammatory markers & diagnostic tools for use in COPD or other respiratory diseases
- Mechanistic studies on the use of anticholinergics (tiotropium) with other (respiratory) drugs and other modes of action, e.g. anti-inflammatory, in the context of COPD or other respiratory diseases
- COPD patient phenotypes or subgroups of the COPD population
Prior to submission, please contact the BIPI Medical IIS Office by calling 877-757-7354 for more information and assistance.
After you contact the BIPI Medical IIS Office researchers or physicians must submit a preliminary proposal. In order for BIPI to determine interest in the IIS concept, the following information will be required in the proposal:
- Full title of the study
- Name and contact of principle investigator
- Study rationale
- Study objectives
- Study design
- Statistical methods
- Data Management Plan/System
- Requested Support (Drug, Funding or both)
- Drug Supply Request (BIPI Drug and/or non-BIPI Drug)
- Preliminary Budget (incl. Direct, Indirect Costs and Fees)
Submission of a preliminary Proposal does not imply or guarantee approval. All proposals will be reviewed based on scientific merit and available funding.
To contact Boehringer Ingelheim Pharmaceuticals, Inc., Medical IIS Office, please call 877-757-7354.
